SCHEMBL26643264

SCHEMBL26643264

Nc1cc(Cl)c(Oc2ccc(=O)n(C3CCCC3)c2)c(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 3/20 0.34
▸ NPBWR1 P48145 1/20 0.33
▸ BMPR1B O00238 2/20 0.32
▸ BMPR1A P36894 2/20 0.32
▸ TGFBR1 P36897 2/20 0.32
▸ ACVRL1 P37023 2/20 0.32
▸ ACVR1 Q04771 2/20 0.32
▸ ATR Q13535 1/20 0.32
▸ LCK P06239 2/20 0.31
▸ KDR P35968 2/20 0.31
▸ TEK Q02763 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ EGFR P00533 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ SRC P12931 2/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ NPSR1 Q6W5P4 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30558175 0.97 BMPR1B (0.32) THRBNPBWR1BMPR1BBMPR1ATGFBR1
SCHEMBL24600451 0.95 THRB (0.31) THRBNPBWR1BMPR1BBMPR1AACVRL1
SCHEMBL26643453 0.83 ALDH1A1 (0.36) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL29066215 0.81 ALDH1A1 (0.36) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL24600323 0.80 PPOX (0.32) NPBWR1LMNA
SCHEMBL24600445 0.80 PDE4A (0.32) NPBWR1MEN1KMT2A
SCHEMBL26643524 0.78 PDE7A (0.37) KDM4EALDH1A1MAPTSMN1; SMN2HSD17B10
SCHEMBL24407922 0.77 THRB (0.48) THRBCYP2C9
SCHEMBL29526743 0.76 THRB (0.40) THRBNPBWR1SMN1; SMN2NPSR1LMNA
SCHEMBL24600252 0.74 CREBBP (0.32) NPBWR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109863-A1 2-PYRIDONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF KPC PHARMACEUTICALS, INC (CN) 2024-04-04 — — US disclosed
EP-4273139-A1 2-PYRIDONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF KPC Pharmaceuticals, Inc. (CN) 2023-11-08 — — EP disclosed
WO-2022143574-A1 2-PYRIDONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF 昆药集团股份有限公司 2022-07-07 — — WO disclosed
CN-114685450-A 2-pyridone derivative, preparation method and medical application thereof 昆药集团股份有限公司 2022-07-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109863-A1 2-PYRIDONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF PTH1R, MC2R, TSHR THRB 16/4885NPBWR1 375/4885BMPR1B 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback